Evidence map›Paper›PMID 41612571›Full record

ArticleEmerging infectious diseases2026

Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024.

Kim Halpin, Raúl Gómez Román, Emmie de Wit, Alison J Peel, Jonathan H Epstein, Jennifer Barr, Sarah J Edwards, Melanie N Tripp, Berta Blanch-Lázaro, Belinda Linnegar and 5 more

Abstract readConference Proceedings
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kim Halpin
Raúl Gómez Román
Emmie de Wit
Alison J Peel
Jonathan H Epstein
Jennifer Barr
Sarah J Edwards
Melanie N Tripp
Berta Blanch-Lázaro
Belinda Linnegar
Gervais Habarugira
Glenn A Marsh
Danielle Anderson
Li-Yen Chang
Wanda Markotter

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diseases caused by henipaviruses, exemplified by Hendra virus and Nipah virus, pose a serious risk to public health because of their epidemic potential and high case-fatality rates and the paucity of medical countermeasures to mitigate them. In December 2024, a group of 150 scientists from 16 countries convened in Geelong, Victoria, Australia, to mark the 30th anniversary of the discovery of Hendra virus. The Hendra@30 conference built upon its predecessor conference held in 2019 in Singapore, Nipah@20, by expanding its program across broader disciplines and integrating sessions on human sociology and disease ecology into the main scientific discussions. We describe key highlights from Hendra@30 and reflect on 4 key elements that have advanced henipavirus research and medical countermeasures research and development. We propose that integrating bat ecology into henipavirus research blueprints will enable development of ecologic countermeasures that prevent spillover and will complement existing preparedness and response efforts with evidence-based prevention strategies.

Indexed as

Hendra VirusHenipavirus InfectionsAnimalsChiropteraHenipavirusHumansNipah VirusPublic HealthAustraliaHendra@30Hendra virushenipavirusNipah virusviruses

Identifiers

PMID41612571
PMCPMC12870148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.